Skip to content

Role of Nidrakar Churna and Shiropichu with Ksheerbala Taila in improving sleep among patients with Insomnia

Clinical evaluation of Nidrakar Churna and Shiropichu with Ksheerbala Taila in Anidra (Insomnia) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095493
Enrollment
60
Registered
2025-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical symptoms of Anidra such as Tandra, Angamarda, Jrumbha, Arati, Klama, Shirashoola and Akshigaurava 2. Patients fulfilling DSM V Criteria for Insomnia 3. Both new and previously treated cases will be included 4. Patients aged between 18 and 70 years 5. Patients of either gender irrespective of their race, occupation, religion and socio economic status 6. Patients who will be capable and willing to adhere to all study related instructions, attend all scheduled visits and sign the consent form

Exclusion criteria

Exclusion criteria: 1. Physiological conditions like pregnancy, lactation and puerperal stage 2. History of any acute systemic pathological illness such as fever in the preceding one month 3. Patients with insomnia comorbid with other medical conditions 4. Patients with impaired Renal, Hepatic or Cardiac function 5. Patients having drug or alcohol dependency 6. Exaggeration of previous psychiatric illness such as major depression and mania 7. Use of hypnotics or other therapies for insomnia within the past 4 weeks

Design outcomes

Primary

MeasureTime frame
1. Improvement in Insomnia Severity Index (ISI) score 2. Improvement in Ayurvedic symptom grading (Tandra, Akshigaurava, Shirashoola, Angamarda, Arati, Klama, Jrumbha)Timepoint: Day 1, Day 30, Day 60

Secondary

MeasureTime frame
Safety and tolerability of the interventionTimepoint: Day 1, Day 30, Day 60

Countries

India

Contacts

Public ContactDR SHUBHAM SADH

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

shubhamsadh@gmail.com8792429267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026